ARTICLE
|
doi:10.20944/preprints202204.0183.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
resistant TNBC; intra-tumoral heterogeneity; breast cancer relapse; breast cancer epigenome; me-tastasis prevention; intrinsic resistance of cancer; tumor adaptability; targeting resistant cancer
Online: 20 April 2022 (04:16:31 CEST)